CI
ARRY

Cowen Inc’s Array Biopharma Inc ARRY Stock Holding History

Cowen Inc’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-47,000
Closed -$393K – 357
2017
Q2 		$393K Buy
47,000
+46,240
+6,084% +$378K 0.02% 233
2017
Q1 		$679K Buy
+760
New +$8.09K 0.03% 150

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cowen Inc's ARRY Position: Q2 2019 in Review

Cowen Inc opened a new position in Array Biopharma Inc (ARRY) in Q2 2019: 217,408 shares worth $10.1M. The stake represents 0.73% of the portfolio and ranks #28 among its holdings. This is a return to the name: Cowen Inc previously reported a position in ARRY as recently as Q2 2017.

Cowen Inc first reported a position in ARRY in Q3 2015 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Cowen Inc held 217,408 shares of Array Biopharma Inc worth $10.1M as of Q2 2019.
  • Array Biopharma Inc was a new Cowen Inc position in Q2 2019.
  • Array Biopharma Inc made up 0.73% of Cowen Inc's portfolio in Q2 2019, its #28 holding.
  • Cowen Inc first reported a position in Array Biopharma Inc in Q3 2015 and has held it in 4 quarters since.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.